Drug Information for TAZORAC (tazarotene) Gel 0.05%(tazarotene) Gel 0.1% (Allergan, Inc.): OVERDOSAGE

Ads
  • Excessive topical use of TAZORAC® Gel may lead to marked redness, peeling, or discomfort (see PRECAUTIONS: General).

    TAZORAC® Gels 0.05% and 0.1% are not for oral use. Oral ingestion of the drug may lead to the same adverse effects as those associated with excessive oral intake of Vitamin A (hypervitaminosis A) or other retinoids. If oral ingestion occurs, the patient should be monitored, and appropriate supportive measures should be administered as necessary.

  • Drug Information Provided by National Library of Medicine (NLM).
Ads